Sanofi SA
OTC:SNYNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
OTC:SNYNF
|
FR |
|
Surmodics Inc
NASDAQ:SRDX
|
US |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
Grupo Rotoplas SAB de CV
OTC:GRPRF
|
MX |
|
B
|
Bombardier Inc
OTC:BDRBF
|
CA |
|
BRP Inc
TSX:DOO
|
CA |
|
Intertrust NV
F:4IT
|
NL |
Wall St Price Targets
SNYNF Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNYNF is 108.85 USD with a low forecast of 65.75 USD and a high forecast of 134.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNYNF's stock price target?
Price Target
108.85
USD
According to Wall Street analysts, the average 1-year price target for SNYNF is 108.85 USD with a low forecast of 65.75 USD and a high forecast of 134.3 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 5%.
